This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Instytut Farmaceutyczny. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Bogdan Zagrodzki
Introduction
Bogdan Zagrodzki is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes and compounds. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Zagrodzki's latest patents include the invention of crystalline polymorphs of methanesulfonic acid addition salts of Imatinib. This invention focuses on the synthesis of crystalline α-form of Imatinib methanesulfonate. Additionally, it introduces a novel acid addition salt of a specific compound with methanesulfonic acid and explores its polymorphic forms and pharmaceutical compositions. Another significant patent is the process for the preparation of imatinib base, which outlines an improved method for synthesizing imatinib and its pharmaceutically acceptable acid addition salts. This process utilizes simple starting materials and streamlines the isolation and purification of intermediates, facilitating scale-up.
Career Highlights
Bogdan Zagrodzki is affiliated with the Instytut Farmaceutyczny, where he continues to innovate in pharmaceutical research. His work has contributed to advancements in drug formulation and synthesis, enhancing the efficacy and accessibility of important medications.
Collaborations
Zagrodzki has collaborated with notable colleagues, including Wojciech Szczepek and Lukasz Kaczmarek. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Bogdan Zagrodzki's contributions to pharmaceutical innovation through his patents and collaborative efforts highlight his role as a significant inventor in the industry. His work continues to impact the development of effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile